IMMUNOCORE HOLDINGS PLC-ADR Share Price Today: Live Updates & Key Insights
IMMUNOCORE HOLDINGS PLC-ADR share price today is $29.9, up -0.43%. The stock opened at $29.98 against the previous close of $30.04, with an intraday high of $30.625 and low of $29.61.
IMMUNOCORE HOLDINGS PLC-ADR Share Price Chart
IMMUNOCORE HOLDINGS PLC-ADR
IMMUNOCORE HOLDINGS PLC-ADR Share Price Performance
IMMUNOCORE HOLDINGS PLC-ADR Institutional Holdings
IMMUNOCORE HOLDINGS PLC-ADR Market Status
IMMUNOCORE HOLDINGS PLC-ADR Fundamentals
Market Cap 1516.29 M
PB Ratio 3.9794
PE Ratio 0.0
Enterprise Value 1088.82 M
Total Assets 1067.27 M
Volume 278976
IMMUNOCORE HOLDINGS PLC-ADR Company Financials
About IMMUNOCORE HOLDINGS PLC-ADR & investment objective
Company Information Immunocore Holdings plc, together with its subsidiaries, engages in the development and commercialization of immunomodulating medicines for patients with cancer, infectious diseases, and autoimmune disease in the United States, Europe, and internationally. The company offers KIMMTRAK for the treatment of unresectable or metastatic uveal melanoma. It also develops oncology programs, including tebentafusp which is in Phase 3 clinical trial for the treatment of advanced cutaneous melanoma and adjuvant uveal melanoma; brenetafusp which is in Phase 3 clinical trial for the treatment of first-line advanced cutaneous melanoma and in Phase 1/2 clinical trial for the treatment of various tumor types; IMC-R117C which is in Phase 1/2 clinical trial for the treatment of advanced solid tumors, such as colorectal cancer; and IMC-P115C which is in Phase 1 clinical trial for patients with tumors that express PRAME. In addition, the company is involved in the development of IMC-M113V which is in Phase 1 clinical trial for a potential functional cure of human immunodeficiency virus; and IMC-I109V which is in Phase 1 clinical trial for a potential functional cure of hepatitis B virus. Further, it develops IMC-S118AI which is in pre-investigation stage for the treatment of type 1 diabetes; and IMC-U120AI which is in pre-investigation stage for the treatment of atopic dermatitis. The company was founded in 1999 and is headquartered in Abingdon, the United Kingdom.
Organisation Biotechnology
Employees 524
Industry Biotechnology
CEO Dr. Bahija Jallal Ph.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
IMMUNOCORE HOLDINGS PLC-ADR FAQs
What is the share price of IMMUNOCORE HOLDINGS PLC-ADR today?
The current share price of IMMUNOCORE HOLDINGS PLC-ADR is $29.9.
Can I buy IMMUNOCORE HOLDINGS PLC-ADR shares in India?
Yes, Indian investors can buy IMMUNOCORE HOLDINGS PLC-ADR shares by opening an international trading and demat account with Motilal Oswal.
How to buy IMMUNOCORE HOLDINGS PLC-ADR shares in India?
You can easily invest in IMMUNOCORE HOLDINGS PLC-ADR shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy IMMUNOCORE HOLDINGS PLC-ADR shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of IMMUNOCORE HOLDINGS PLC-ADR.
Can I buy fractional shares of IMMUNOCORE HOLDINGS PLC-ADR?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of IMMUNOCORE HOLDINGS PLC-ADR?
IMMUNOCORE HOLDINGS PLC-ADR has a market cap of $1516.29 M.
In which sector does IMMUNOCORE HOLDINGS PLC-ADR belong?
IMMUNOCORE HOLDINGS PLC-ADR operates in the Biotechnology sector.
What documents are required to invest in IMMUNOCORE HOLDINGS PLC-ADR stocks?
To invest, you typically need:
What is the PE and PB ratio of IMMUNOCORE HOLDINGS PLC-ADR?
The PE ratio of IMMUNOCORE HOLDINGS PLC-ADR is N/A and the PB ratio is 3.98.